Literature DB >> 21467034

Regulation of collagen fibril nucleation and initial fibril assembly involves coordinate interactions with collagens V and XI in developing tendon.

Richard J Wenstrup1, Simone M Smith, Jane B Florer, Guiyun Zhang, David P Beason, Robert E Seegmiller, Louis J Soslowsky, David E Birk.   

Abstract

Collagens V and XI comprise a single regulatory type of fibril-forming collagen with multiple isoforms. Both co-assemble with collagen I or II to form heterotypic fibrils and have been implicated in regulation of fibril assembly. The objective of this study was to determine the roles of collagens V and XI in the regulation of tendon fibrillogenesis. Flexor digitorum longus tendons from a haplo-insufficient collagen V mouse model of classic Ehlers Danlos syndrome (EDS) had decreased biomechanical stiffness compared with controls consistent with joint laxity in EDS patients. However, fibril structure was relatively normal, an unexpected finding given the altered fibrils observed in dermis and cornea from this model. This suggested roles for other related molecules, i.e. collagen XI, and compound Col5a1(+/-),Col11a1(+/-) tendons had altered fibril structures, supporting a role for collagen XI. To further evaluate this, transcript expression was analyzed in wild type tendons. During development (E18-P10) both collagen V and XI were comparably expressed; however, collagen V predominated in mature (P30) tendons. The collagens had a similar expression pattern. Tendons with altered collagen V and/or XI expression (Col5a1(+/-); Col11a1(+/-); Col5a1(+/-),Col11a1(+/-); Col11a1(-/-); Col5a1(+/-),Col11a1(-/-)) were analyzed at E18. All genotypes demonstrated a reduced fibril number and altered structure. This phenotype was more severe with a reduction in collagen XI. However, the absence of collagen XI with a reduction in collagen V was associated with the most severe fibril phenotype. The data demonstrate coordinate roles for collagens V and XI in the regulation of fibril nucleation and assembly during tendon development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467034      PMCID: PMC3121453          DOI: 10.1074/jbc.M111.223693

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.

Authors:  A De Paepe; L Nuytinck; I Hausser; I Anton-Lamprecht; J M Naeyaert
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II.

Authors:  N P Burrows; A C Nicholls; J R Yates; G Gatward; P Sarathachandra; A Richards; F M Pope
Journal:  J Invest Dermatol       Date:  1996-06       Impact factor: 8.551

3.  Collagen fibrillogenesis in situ: fibril segments become long fibrils as the developing tendon matures.

Authors:  D E Birk; E I Zycband; S Woodruff; D A Winkelmann; R L Trelstad
Journal:  Dev Dyn       Date:  1997-03       Impact factor: 3.780

4.  A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I).

Authors:  R J Wenstrup; G T Langland; M C Willing; V N D'Souza; W G Cole
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

5.  Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes.

Authors:  N P Burrows; A C Nicholls; J R Yates; A J Richards; F M Pope
Journal:  Clin Exp Dermatol       Date:  1997-07       Impact factor: 3.470

6.  Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I.

Authors:  K Michalickova; M Susic; M C Willing; R J Wenstrup; W G Cole
Journal:  Hum Mol Genet       Date:  1998-02       Impact factor: 6.150

7.  An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.

Authors:  A C Nicholls; J E Oliver; S McCarron; J B Harrison; D S Greenspan; F M Pope
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

8.  Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone.

Authors:  S W Li; D J Prockop; H Helminen; R Fässler; T Lapveteläinen; K Kiraly; A Peltarri; J Arokoski; H Lui; M Arita
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

9.  A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II.

Authors:  A J Richards; S Martin; A C Nicholls; J B Harrison; F M Pope; N P Burrows
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

10.  Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1).

Authors:  H Yoshioka; K Iyama; K Inoguchi; M Khaleduzzaman; Y Ninomiya; F Ramirez
Journal:  Dev Dyn       Date:  1995-09       Impact factor: 3.780

View more
  45 in total

1.  Collagen V-heterozygous and -null supraspinatus tendons exhibit altered dynamic mechanical behaviour at multiple hierarchical scales.

Authors:  Brianne K Connizzo; Lin Han; David E Birk; Louis J Soslowsky
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

2.  Regulatory role of collagen V in establishing mechanical properties of tendons and ligaments is tissue dependent.

Authors:  Brianne K Connizzo; Benjamin R Freedman; Joanna H Fried; Mei Sun; David E Birk; Louis J Soslowsky
Journal:  J Orthop Res       Date:  2015-04-27       Impact factor: 3.494

3.  Plexin D1 determines body fat distribution by regulating the type V collagen microenvironment in visceral adipose tissue.

Authors:  James E N Minchin; Ingrid Dahlman; Christopher J Harvey; Niklas Mejhert; Manvendra K Singh; Jonathan A Epstein; Peter Arner; Jesús Torres-Vázquez; John F Rawls
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 4.  Functional tissue engineering of tendon: Establishing biological success criteria for improving tendon repair.

Authors:  Andrew P Breidenbach; Steven D Gilday; Andrea L Lalley; Nathaniel A Dyment; Cynthia Gooch; Jason T Shearn; David L Butler
Journal:  J Biomech       Date:  2013-10-22       Impact factor: 2.712

5.  Scaffold fiber diameter regulates human tendon fibroblast growth and differentiation.

Authors:  Cevat Erisken; Xin Zhang; Kristen L Moffat; William N Levine; Helen H Lu
Journal:  Tissue Eng Part A       Date:  2012-11-14       Impact factor: 3.845

6.  A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.

Authors:  Dongyu Jia; Zhenqiu Liu; Nan Deng; Tuan Zea Tan; Ruby Yun-Ju Huang; Barbie Taylor-Harding; Dong-Joo Cheon; Kate Lawrenson; Wolf R Wiedemeyer; Ann E Walts; Beth Y Karlan; Sandra Orsulic
Journal:  Cancer Lett       Date:  2016-09-05       Impact factor: 8.679

Review 7.  The role of mechanobiology in tendon healing.

Authors:  Megan L Killian; Leonardo Cavinatto; Leesa M Galatz; Stavros Thomopoulos
Journal:  J Shoulder Elbow Surg       Date:  2012-02       Impact factor: 3.019

8.  Collagen V expression is crucial in regional development of the supraspinatus tendon.

Authors:  Brianne K Connizzo; Sheila M Adams; Thomas H Adams; David E Birk; Louis J Soslowsky
Journal:  J Orthop Res       Date:  2016-04-07       Impact factor: 3.494

9.  Mineralization of the vertebral bodies in Atlantic salmon (Salmo salar L.) is initiated segmentally in the form of hydroxyapatite crystal accretions in the notochord sheath.

Authors:  Shou Wang; Harald Kryvi; Sindre Grotmol; Anna Wargelius; Christel Krossøy; Mattias Epple; Frank Neues; Tomasz Furmanek; Geir K Totland
Journal:  J Anat       Date:  2013-05-27       Impact factor: 2.610

Review 10.  The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.

Authors:  Shoujun Chen; David E Birk
Journal:  FEBS J       Date:  2013-02-14       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.